Drug · DIN 02424991
MINT-HYDROXYCHLOROQUINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 10, 2014; first marketed June 10, 2014.
- Drug Identification Number (DIN)
- 02424991
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Hydroxychloroquine P01BA02
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HYDROXYCHLOROQUINE SULFATE | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 26, 2014: NOC 15636Abbreviated New Drug Submission (ANDS)